Age-related macular degeneration (AMD) remains the leading cause of irreversible vision loss in Australia. This webinar, by researchers from the Macular Research Unit, Centre for Eye Research Australia (CERA), will provide an update on our current knowledge of AMD and findings from their latest research. It will also discuss new, ongoing studies at CERA of trials of new treatments or studies to help find new treatments for AMD, and how you can get involved.
About the presenters:
Dr Zhichao Wu is an optometrist and senior research fellow at the Centre for Eye Research Australia (CERA) and Ophthalmology, Department of Surgery, The University of Melbourne. He completed his PhD at CERA in 2014, and he subsequently received the NHMRC Neil Hamilton Fairley Clinical Research Fellowship in 2016 to work with leading researchers at the University of California, San Diego and Columbia University. He returned to Australia in 2018 to continue in research that seeks to prevent irreversible vision loss especially from early eye diseases (such as age-related macular degeneration) by providing innovative diagnostics for clinical management and expediting the discovery of new treatments.
Tony Pham graduated in 2016 as an Orthoptist at Latrobe University in Melbourne. After graduating, Tony worked in the private sector at the Victorian Parade Eye Consultants (VPEC) for 3 years. He had the opportunity to work alongside reputable professors and doctors within the eye industry, some of which are the current principal investigators at Centre for Eye Research Australia (CERA). Tony has recently joined CERA, working within the Macular Research Unit, as a Clinical Trial Coordinator.
Find out more: www.mdfoundation.com.au
